Latest From Biotech Now

Confessions of a Cancer-Free Cancer Patient

Sandra Dennis

By Sandra Dennis, Deputy General Counsel for Healthcare, the Biotechnology Industry Organization October is breast cancer awareness month. As a dear friend said to me recently — it’s a whole month? She also despises the whole pink ribbon thing. I didn’t dare mention to her that there’s a breast cancer stamp. While it could suggest a lack of empathy, she was treated for breast cancer several years ago, so she speaks from the perspective of Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , ,

Medical Innovation at Risk

Scientists

The National Venture Capital Association’s MedIC Coalition recently released a report showing U.S. venture capitalists are decreasing their investments in biopharmaceutical and medical device companies, reducing their concentration in prevalent disease areas and shifting investments towards Europe and Asia. The report, Vital Signs: The Threat to Investment in U.S. Medical Innovation and the Imperative of FDA Reform, strongly indicates that America’s medical innovation economy is in grave danger of losing its primary source of funding, Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Bioterrorism: Ten Years Later

Report Card Graphic 10 11 11

By Bob Graham, Jim Talent, Randy Larsen & Lynne Kidder of The WMD Center Ten years ago this week, while still in shock from the unspeakable horrors of 9/11, Americans were learning of a new threat—bioterrorism. As it turns out, the anthrax letters of October 2001 were a relatively small incident, in which 22 were infected and five died. Other than the psychological aspects and the costs of cleanup (in excess of $500 million), the Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Perspective on Market Valuation for Biotech Drug Developers

Graph

Of the 300 publicly traded U.S. biotechs, 219 (73%) are developing drugs. The other 27% are working on molecular tools, diagnostics, biofuels, and other biotech endeavors. One question that is often asked with respect to drug-focused biotechs is: How big are they compared to traditional pharmaceutical companies? How many are valued as small start-ups vs large, or mid-size pharmas? It turns out that more than half the sector trades with a market valuation of less Read More >

Inside BIO Industry Analysis  |  1 Comment  |  Email This Post
Tags: , , , , , , ,

Boosting Investment in Biotech

Biofuel Research

The President’s Council on Jobs and Competitiveness issued an interim report with suggestions to increase job creation and growth in the U.S., as well as plans for encouraging investment in the industry. Of particular interest to the biotech industry, the report offers suggestions for streamlining the FDA approval process. The report also outlines ideas for eliminating capital gains on investments of $25 million or less that are held for at least five years and recommends Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,